Pharmacogenomics of hepatitis C and decision analysis: a glimpse into the future
Hepatology
.
2002 Jul;36(1):252-4.
doi: 10.1053/jhep.2002.00000.
Author
John B Wong
1
Affiliation
1
Division of Clinical Decision Making, Department of Medicine, Tupper Research Institute, Tufts-New England Medical Center, Tufts University School of Medicine, 750 Washington Street, Boston, MA 02111, USA.
[email protected]
PMID:
12085373
DOI:
10.1053/jhep.2002.00000
No abstract available
Publication types
Comment
Editorial
MeSH terms
Antiviral Agents / therapeutic use
Genotype
Hepacivirus / genetics*
Hepatitis C / drug therapy*
Humans
Markov Chains
Pharmacogenetics*
Substances
Antiviral Agents